Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart van Hoek

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|April 17, 2018
Utilizing Mechanistic Biomarkers in Treating Paracetamol HepatotoxicityRowan F van Golen, Megan J Reiniers, Jacqueline van Gorp, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Protein energy malnutrition predicts complications in liver cirrhosisEllen J Huisman, Evelien J Trip, Peter D Siersema, et al.
Journal of Medical Economics|October 11, 2021
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The NetherlandsLisa Aniek de Jong, Alexander Victor van Schoonhoven, Hinko Stephan Hofstra, et al.
Clinical Genitourinary Cancer|June 29, 2019
Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic TransplantMerel van Nuland, Julie M Janssen, Bart van Hoek, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 5, 2023
Prevalence of non-alcoholic fatty liver in the general Dutch population and in groups at increased riskGabrielle Alblas, Hildo J Lamb, Frits R Rosendaal, et al.
Journal of Hepatology|March 30, 2024
Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis"Romée J A L M Snijders, Anna E C Stoelinga, Bart van Hoek, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 21, 2015
Combined effect of donor and recipient risk on outcome after liver transplantation: Research of the Eurotransplant databaseJoris J Blok, Hein Putter, Xavier Rogiers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatmentCharlotte G Krol, Olaf M Dekkers, Herman M Kroon, et al.
Annals of Surgery|January 10, 2014
Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcome from a single centerJeroen Dubbeld, Bart van Hoek, Jan Ringers, et al.
Clinical Transplantation|October 4, 2022
Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trialBastian N Ruijter, Maarten E Tushuizen, Dirk J A R Moes, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|April 17, 2018
Utilizing Mechanistic Biomarkers in Treating Paracetamol HepatotoxicityRowan F van Golen, Megan J Reiniers, Jacqueline van Gorp, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Protein energy malnutrition predicts complications in liver cirrhosisEllen J Huisman, Evelien J Trip, Peter D Siersema, et al.
Journal of Medical Economics|October 11, 2021
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The NetherlandsLisa Aniek de Jong, Alexander Victor van Schoonhoven, Hinko Stephan Hofstra, et al.
Clinical Genitourinary Cancer|June 29, 2019
Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic TransplantMerel van Nuland, Julie M Janssen, Bart van Hoek, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 5, 2023
Prevalence of non-alcoholic fatty liver in the general Dutch population and in groups at increased riskGabrielle Alblas, Hildo J Lamb, Frits R Rosendaal, et al.
Journal of Hepatology|March 30, 2024
Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis"Romée J A L M Snijders, Anna E C Stoelinga, Bart van Hoek, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 21, 2015
Combined effect of donor and recipient risk on outcome after liver transplantation: Research of the Eurotransplant databaseJoris J Blok, Hein Putter, Xavier Rogiers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatmentCharlotte G Krol, Olaf M Dekkers, Herman M Kroon, et al.
Annals of Surgery|January 10, 2014
Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcome from a single centerJeroen Dubbeld, Bart van Hoek, Jan Ringers, et al.
Clinical Transplantation|October 4, 2022
Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trialBastian N Ruijter, Maarten E Tushuizen, Dirk J A R Moes, et al.
Pageof 19